1. Home
  2. SGMT vs SLND Comparison

SGMT vs SLND Comparison

Compare SGMT & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • SLND
  • Stock Information
  • Founded
  • SGMT 2006
  • SLND 1900
  • Country
  • SGMT United States
  • SLND United States
  • Employees
  • SGMT N/A
  • SLND 2500
  • Industry
  • SGMT
  • SLND Military/Government/Technical
  • Sector
  • SGMT
  • SLND Industrials
  • Exchange
  • SGMT Nasdaq
  • SLND Nasdaq
  • Market Cap
  • SGMT 159.0M
  • SLND 188.8M
  • IPO Year
  • SGMT 2023
  • SLND N/A
  • Fundamental
  • Price
  • SGMT $4.39
  • SLND $3.50
  • Analyst Decision
  • SGMT Buy
  • SLND Buy
  • Analyst Count
  • SGMT 6
  • SLND 2
  • Target Price
  • SGMT $23.00
  • SLND $5.50
  • AVG Volume (30 Days)
  • SGMT 1.2M
  • SLND 45.7K
  • Earning Date
  • SGMT 11-13-2024
  • SLND 03-03-2025
  • Dividend Yield
  • SGMT N/A
  • SLND N/A
  • EPS Growth
  • SGMT N/A
  • SLND N/A
  • EPS
  • SGMT N/A
  • SLND N/A
  • Revenue
  • SGMT N/A
  • SLND $1,029,117,999.00
  • Revenue This Year
  • SGMT N/A
  • SLND N/A
  • Revenue Next Year
  • SGMT N/A
  • SLND $6.18
  • P/E Ratio
  • SGMT N/A
  • SLND N/A
  • Revenue Growth
  • SGMT N/A
  • SLND N/A
  • 52 Week Low
  • SGMT $2.39
  • SLND $1.85
  • 52 Week High
  • SGMT $20.71
  • SLND $6.16
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 44.30
  • SLND 54.30
  • Support Level
  • SGMT $4.06
  • SLND $3.15
  • Resistance Level
  • SGMT $7.38
  • SLND $3.86
  • Average True Range (ATR)
  • SGMT 0.63
  • SLND 0.26
  • MACD
  • SGMT -0.11
  • SLND -0.00
  • Stochastic Oscillator
  • SGMT 9.94
  • SLND 49.30

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.

Share on Social Networks: